Julaeha, J. (2021) “Metabolic Syndrome Risk Associated with Atypical Antipsychotic Medication: A Case Report”, Journal of Drug Delivery and Therapeutics, 11(1), pp. 77–79. doi:10.22270/jddt.v11i1.4680.